nifedipine has been researched along with Day Blindness in 8 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the effects of nilvadipine on the progression of central visual field defect in retinitis pigmentosa (RP)." | 9.15 | Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial. ( Ito, T; Metoki, T; Miyagawa, Y; Nakazawa, M; Ohguro, H; Takeuchi, K, 2011) |
| "Several notifications of eye pain and blurred vision associated with treatment with nifedipine were received by New Zealand's Intensive Medicines Monitoring Programme." | 7.67 | Eye pain with nifedipine and disturbance of taste with captopril: a mutually controlled study showing a method of postmarketing surveillance. ( Coulter, DM, 1988) |
| "To assess the effects of nilvadipine on the progression of central visual field defect in retinitis pigmentosa (RP)." | 5.15 | Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial. ( Ito, T; Metoki, T; Miyagawa, Y; Nakazawa, M; Ohguro, H; Takeuchi, K, 2011) |
| "Several notifications of eye pain and blurred vision associated with treatment with nifedipine were received by New Zealand's Intensive Medicines Monitoring Programme." | 3.67 | Eye pain with nifedipine and disturbance of taste with captopril: a mutually controlled study showing a method of postmarketing surveillance. ( Coulter, DM, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, J | 1 |
| Liu, H | 1 |
| Zhang, L | 1 |
| Ma, L | 1 |
| Zhou, H | 1 |
| Pitkänen, H | 1 |
| Saarela, V | 1 |
| Nakazawa, M | 1 |
| Ohguro, H | 1 |
| Takeuchi, K | 1 |
| Miyagawa, Y | 1 |
| Ito, T | 1 |
| Metoki, T | 1 |
| Rodenas, M | 1 |
| Kumar, S | 1 |
| Freund, KB | 1 |
| Moallem, J | 1 |
| Das, CJ | 1 |
| Seith, A | 1 |
| Netland, PA | 1 |
| Chaturvedi, N | 1 |
| Dreyer, EB | 1 |
| Coulter, DM | 1 |
| Gasser, P | 1 |
| Flammer, J | 1 |
| Mahler, F | 1 |
1 trial available for nifedipine and Day Blindness
| Article | Year |
|---|---|
Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial.
Topics: Administration, Oral; Adult; Aged; Calcium Channel Blockers; Disease Progression; Female; Follow-Up | 2011 |
7 other studies available for nifedipine and Day Blindness
| Article | Year |
|---|---|
Corkscrew retinal vessels and retinal arterial macroaneurysm in a patient with neurofibromatosis type 1: A case report.
Topics: Aged; Aneurysm; Angiography; Female; Fluorescein Angiography; Humans; Indocyanine Green; Neurofibrom | 2018 |
Vasospastic transient monocular visual loss: effect of treatment with different doses of nifedipine.
Topics: Adult; Calcium Channel Blockers; Female; Functional Laterality; Humans; Magnetic Resonance Imaging; | 2014 |
Retinitis preceding systemic lupus erythematosus in absence of anti-phospholipid antibodies.
Topics: Adolescent; Antibodies, Antiphospholipid; Atenolol; Cyclophosphamide; Diagnosis, Differential; Drug | 2012 |
Posterior reversible encephalopathy syndrome (PRES).
Topics: Brain Edema; Child, Preschool; Humans; Hypertensive Encephalopathy; Magnetic Resonance Imaging; Male | 2006 |
Calcium channel blockers in the management of low-tension and open-angle glaucoma.
Topics: Administration, Oral; Aged; Aged, 80 and over; Calcium Channel Blockers; Diltiazem; Female; Follow-U | 1993 |
Eye pain with nifedipine and disturbance of taste with captopril: a mutually controlled study showing a method of postmarketing surveillance.
Topics: Adolescent; Adult; Aged; Captopril; Child; Evaluation Studies as Topic; Eye Diseases; Female; Humans | 1988 |
[The use of calcium antagonists in the treatment of ocular circulation symptoms in the framework of a vasospastic syndrome].
Topics: Calcium Channel Blockers; Humans; Nifedipine; Raynaud Disease; Retinal Diseases; Vasoconstriction; V | 1988 |